Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-04

Clinical Trial Update: Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing lamotrigine alone to lamotrigine plus an antidepressant for bipolar II disorder with a depressive episode has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: University of British Columbia | Conditions: Bipolar II Disorder, Most Recent Episode Major Depressive | Phase 2 | Status: COMPLETED